Global Therapeutic Peptide Market Research Report 2021

1 Therapeutic Peptide Market Overview

• 1.1 Product Overview and Scope of Therapeutic Peptide
• 1.2 Therapeutic Peptide Segment by Type
  • 1.2.1 Global Therapeutic Peptide Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Oral
  • 1.2.3 Injection
  • 1.2.4 Other
• 1.3 Therapeutic Peptide Segment by Application
  • 1.3.1 Global Therapeutic Peptide Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cancer
  • 1.3.3 Metabolic Disorders
  • 1.3.4 Central Nervous System
  • 1.3.5 Other
• 1.4 Global Therapeutic Peptide Market Size Estimates and Forecasts
  • 1.4.1 Global Therapeutic Peptide Revenue 2016-2027
  • 1.4.2 Global Therapeutic Peptide Sales 2016-2027
  • 1.4.3 Therapeutic Peptide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Therapeutic Peptide Market Competition by Manufacturers

• 2.1 Global Therapeutic Peptide Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Therapeutic Peptide Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Therapeutic Peptide Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Therapeutic Peptide Manufacturing Sites, Area Served, Product Type
• 2.5 Therapeutic Peptide Market Competitive Situation and Trends
  • 2.5.1 Therapeutic Peptide Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Peptide Players Market Share by Revenue
  • 2.5.3 Global Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Therapeutic Peptide Retrospective Market Scenario by Region

• 3.1 Global Therapeutic Peptide Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Therapeutic Peptide Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Therapeutic Peptide Market Facts & Figures by Country
  • 3.3.1 North America Therapeutic Peptide Sales by Country
  • 3.3.2 North America Therapeutic Peptide Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Therapeutic Peptide Market Facts & Figures by Country
  • 3.4.1 Europe Therapeutic Peptide Sales by Country
  • 3.4.2 Europe Therapeutic Peptide Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Therapeutic Peptide Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Therapeutic Peptide Sales by Region
  • 3.5.2 Asia Pacific Therapeutic Peptide Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Therapeutic Peptide Market Facts & Figures by Country
  • 3.6.1 Latin America Therapeutic Peptide Sales by Country
  • 3.6.2 Latin America Therapeutic Peptide Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Therapeutic Peptide Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Therapeutic Peptide Sales by Country
  • 3.7.2 Middle East and Africa Therapeutic Peptide Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Therapeutic Peptide Historic Market Analysis by Type

• 4.1 Global Therapeutic Peptide Sales Market Share by Type (2016-2021)
• 4.2 Global Therapeutic Peptide Revenue Market Share by Type (2016-2021)
• 4.3 Global Therapeutic Peptide Price by Type (2016-2021)

5 Global Therapeutic Peptide Historic Market Analysis by Application

• 5.1 Global Therapeutic Peptide Sales Market Share by Application (2016-2021)
• 5.2 Global Therapeutic Peptide Revenue Market Share by Application (2016-2021)
• 5.3 Global Therapeutic Peptide Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 AbbVie
  • 6.1.1 AbbVie Corporation Information
  • 6.1.2 AbbVie Description and Business Overview
  • 6.1.3 AbbVie Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 AbbVie Therapeutic Peptide Product Portfolio
  • 6.1.5 AbbVie Recent Developments/Updates
• 6.2 AstraZeneca
  • 6.2.1 AstraZeneca Corporation Information
  • 6.2.2 AstraZeneca Description and Business Overview
  • 6.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 AstraZeneca Therapeutic Peptide Product Portfolio
  • 6.2.5 AstraZeneca Recent Developments/Updates
• 6.3 Ipsen
  • 6.3.1 Ipsen Corporation Information
  • 6.3.2 Ipsen Description and Business Overview
  • 6.3.3 Ipsen Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Ipsen Therapeutic Peptide Product Portfolio
  • 6.3.5 Ipsen Recent Developments/Updates
• 6.4 Eli Lilly
  • 6.4.1 Eli Lilly Corporation Information
  • 6.4.2 Eli Lilly Description and Business Overview
  • 6.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Eli Lilly Therapeutic Peptide Product Portfolio
  • 6.4.5 Eli Lilly Recent Developments/Updates
• 6.5 Merck
  • 6.5.1 Merck Corporation Information
  • 6.5.2 Merck Description and Business Overview
  • 6.5.3 Merck Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Merck Therapeutic Peptide Product Portfolio
  • 6.5.5 Merck Recent Developments/Updates
• 6.6 Novo Nordisk
  • 6.6.1 Novo Nordisk Corporation Information
  • 6.6.2 Novo Nordisk Description and Business Overview
  • 6.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Novo Nordisk Therapeutic Peptide Product Portfolio
  • 6.6.5 Novo Nordisk Recent Developments/Updates
• 6.7 Novartis
  • 6.6.1 Novartis Corporation Information
  • 6.6.2 Novartis Description and Business Overview
  • 6.6.3 Novartis Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Novartis Therapeutic Peptide Product Portfolio
  • 6.7.5 Novartis Recent Developments/Updates
• 6.8 Johnson and Johnson
  • 6.8.1 Johnson and Johnson Corporation Information
  • 6.8.2 Johnson and Johnson Description and Business Overview
  • 6.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Johnson and Johnson Therapeutic Peptide Product Portfolio
  • 6.8.5 Johnson and Johnson Recent Developments/Updates
• 6.9 Sanofi
  • 6.9.1 Sanofi Corporation Information
  • 6.9.2 Sanofi Description and Business Overview
  • 6.9.3 Sanofi Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Sanofi Therapeutic Peptide Product Portfolio
  • 6.9.5 Sanofi Recent Developments/Updates
• 6.10 Teva
  • 6.10.1 Teva Corporation Information
  • 6.10.2 Teva Description and Business Overview
  • 6.10.3 Teva Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Teva Therapeutic Peptide Product Portfolio
  • 6.10.5 Teva Recent Developments/Updates
• 6.11 Takeda
  • 6.11.1 Takeda Corporation Information
  • 6.11.2 Takeda Therapeutic Peptide Description and Business Overview
  • 6.11.3 Takeda Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Takeda Therapeutic Peptide Product Portfolio
  • 6.11.5 Takeda Recent Developments/Updates

7 Therapeutic Peptide Manufacturing Cost Analysis

• 7.1 Therapeutic Peptide Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Therapeutic Peptide
• 7.4 Therapeutic Peptide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Therapeutic Peptide Distributors List
• 8.3 Therapeutic Peptide Customers

9 Therapeutic Peptide Market Dynamics

• 9.1 Therapeutic Peptide Industry Trends
• 9.2 Therapeutic Peptide Growth Drivers
• 9.3 Therapeutic Peptide Market Challenges
• 9.4 Therapeutic Peptide Market Restraints

10 Global Market Forecast

• 10.1 Therapeutic Peptide Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Therapeutic Peptide by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Therapeutic Peptide by Type (2022-2027)
• 10.2 Therapeutic Peptide Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Therapeutic Peptide by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Therapeutic Peptide by Application (2022-2027)
• 10.3 Therapeutic Peptide Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Therapeutic Peptide by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Therapeutic Peptide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List